Status:

RECRUITING

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

Lead Sponsor:

Kansas City Heart Rhythm Research Foundation

Conditions:

Atrial Fibrillation

Hemostasis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual ...

Detailed Description

The volume of catheter ablation procedures for the treatment of atrial fibrillation and other arrhythmias are on the rise in the United States and worldwide. Despite decrease in complication rates due...

Eligibility Criteria

Inclusion

  • Must be at least 18 years of age
  • Be able to provide consent
  • Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound.

Exclusion

  • Under the age of 18
  • Unable to or unwilling to provide consent
  • Cannot comply with study requirements
  • Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle
  • Subjects whose physician does not use LockeT or MC to close the venous puncture.
  • Patient is currently pregnant, as evidenced by positive urine Beta-HCG. (Urine Beta Human chorionic gonadotropin (HCG) will be checked in all females of the reproductive age group).
  • If the physician detects a formed hematoma prior to venous closure, that patient will be excluded from the study.

Key Trial Info

Start Date :

October 2 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT06078735

Start Date

October 2 2023

End Date

December 1 2024

Last Update

October 29 2024

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Kansas City Heart Rhythm Institute - Roe Clinic

Overland Park, Kansas, United States, 66211

2

Overland Park Regional Medical Center

Overland Park, Kansas, United States, 66215

3

Centerpoint Medical Center Clinic

Independence, Missouri, United States, 64057

4

Centerpoint Medical Center

Independence, Missouri, United States, 64057

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study | DecenTrialz